Pharma & Healthcare
Global Crizotinib Capsules Market Research Report 2026
- Mar 17, 26
- ID: 741021
- Pages: 117
- Figures: 117
- Views: 1
This report delivers a comprehensive overview of the global Crizotinib Capsules market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Crizotinib Capsules. The Crizotinib Capsules market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Crizotinib Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Crizotinib Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Qilu Pharmaceutical
Jiangsu Hengrui Medicine
Chia Tai Tianqing Pharmaceutical Group
Cipla Limited
Glenmark Pharmaceuticals
Natco Pharma
Segment by Type
200mg
250mg
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Crizotinib Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Crizotinib Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Crizotinib Capsules market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Crizotinib Capsules manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Qilu Pharmaceutical
Jiangsu Hengrui Medicine
Chia Tai Tianqing Pharmaceutical Group
Cipla Limited
Glenmark Pharmaceuticals
Natco Pharma
Segment by Type
200mg
250mg
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Crizotinib Capsules manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Crizotinib Capsules sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Crizotinib Capsules Market Overview
1.1 Product Definition
1.2 Crizotinib Capsules by Type
1.2.1 Global Crizotinib Capsules Market Value by Type: 2025 vs 2032
1.2.2 200mg
1.2.3 250mg
1.3 Crizotinib Capsules by Application
1.3.1 Global Crizotinib Capsules Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Crizotinib Capsules Market Size Estimates and Forecasts
1.4.1 Global Crizotinib Capsules Revenue 2021–2032
1.4.2 Global Crizotinib Capsules Sales 2021–2032
1.4.3 Global Crizotinib Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Crizotinib Capsules Market Competition by Manufacturers
2.1 Global Crizotinib Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Crizotinib Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Crizotinib Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Crizotinib Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Crizotinib Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Crizotinib Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Crizotinib Capsules, Date of Entry into the Industry
2.8 Global Crizotinib Capsules Market Competitive Situation and Trends
2.8.1 Global Crizotinib Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Crizotinib Capsules Players Market Share by Revenue
2.8.3 Global Crizotinib Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Crizotinib Capsules Market Scenario by Region
3.1 Global Crizotinib Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Crizotinib Capsules Sales by Region: 2021–2032
3.2.1 Global Crizotinib Capsules Sales by Region: 2021–2026
3.2.2 Global Crizotinib Capsules Sales by Region: 2027–2032
3.3 Global Crizotinib Capsules Revenue by Region: 2021–2032
3.3.1 Global Crizotinib Capsules Revenue by Region: 2021–2026
3.3.2 Global Crizotinib Capsules Revenue by Region: 2027–2032
3.4 North America Crizotinib Capsules Market Facts & Figures by Country
3.4.1 North America Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Crizotinib Capsules Sales by Country (2021–2032)
3.4.3 North America Crizotinib Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Crizotinib Capsules Market Facts & Figures by Country
3.5.1 Europe Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Crizotinib Capsules Sales by Country (2021–2032)
3.5.3 Europe Crizotinib Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crizotinib Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Crizotinib Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Crizotinib Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Crizotinib Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Crizotinib Capsules Market Facts & Figures by Country
3.7.1 Latin America Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Crizotinib Capsules Sales by Country (2021–2032)
3.7.3 Latin America Crizotinib Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Crizotinib Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Crizotinib Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Crizotinib Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crizotinib Capsules Sales by Type (2021–2032)
4.1.1 Global Crizotinib Capsules Sales by Type (2021–2026)
4.1.2 Global Crizotinib Capsules Sales by Type (2027–2032)
4.1.3 Global Crizotinib Capsules Sales Market Share by Type (2021–2032)
4.2 Global Crizotinib Capsules Revenue by Type (2021–2032)
4.2.1 Global Crizotinib Capsules Revenue by Type (2021–2026)
4.2.2 Global Crizotinib Capsules Revenue by Type (2027–2032)
4.2.3 Global Crizotinib Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Crizotinib Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Crizotinib Capsules Sales by Application (2021–2032)
5.1.1 Global Crizotinib Capsules Sales by Application (2021–2026)
5.1.2 Global Crizotinib Capsules Sales by Application (2027–2032)
5.1.3 Global Crizotinib Capsules Sales Market Share by Application (2021–2032)
5.2 Global Crizotinib Capsules Revenue by Application (2021–2032)
5.2.1 Global Crizotinib Capsules Revenue by Application (2021–2026)
5.2.2 Global Crizotinib Capsules Revenue by Application (2027–2032)
5.2.3 Global Crizotinib Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Crizotinib Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Crizotinib Capsules Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Qilu Pharmaceutical
6.2.1 Qilu Pharmaceutical Company Information
6.2.2 Qilu Pharmaceutical Description and Business Overview
6.2.3 Qilu Pharmaceutical Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Qilu Pharmaceutical Crizotinib Capsules Product Portfolio
6.2.5 Qilu Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Hengrui Medicine
6.3.1 Jiangsu Hengrui Medicine Company Information
6.3.2 Jiangsu Hengrui Medicine Description and Business Overview
6.3.3 Jiangsu Hengrui Medicine Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio
6.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.4 Chia Tai Tianqing Pharmaceutical Group
6.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.4.3 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio
6.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.5 Cipla Limited
6.5.1 Cipla Limited Company Information
6.5.2 Cipla Limited Description and Business Overview
6.5.3 Cipla Limited Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Limited Crizotinib Capsules Product Portfolio
6.5.5 Cipla Limited Recent Developments/Updates
6.6 Glenmark Pharmaceuticals
6.6.1 Glenmark Pharmaceuticals Company Information
6.6.2 Glenmark Pharmaceuticals Description and Business Overview
6.6.3 Glenmark Pharmaceuticals Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio
6.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.7 Natco Pharma
6.7.1 Natco Pharma Company Information
6.7.2 Natco Pharma Description and Business Overview
6.7.3 Natco Pharma Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Natco Pharma Crizotinib Capsules Product Portfolio
6.7.5 Natco Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crizotinib Capsules Industry Chain Analysis
7.2 Crizotinib Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crizotinib Capsules Production Mode & Process Analysis
7.4 Crizotinib Capsules Sales and Marketing
7.4.1 Crizotinib Capsules Sales Channels
7.4.2 Crizotinib Capsules Distributors
7.5 Crizotinib Capsules Customer Analysis
8 Crizotinib Capsules Market Dynamics
8.1 Crizotinib Capsules Industry Trends
8.2 Crizotinib Capsules Market Drivers
8.3 Crizotinib Capsules Market Challenges
8.4 Crizotinib Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Crizotinib Capsules by Type
1.2.1 Global Crizotinib Capsules Market Value by Type: 2025 vs 2032
1.2.2 200mg
1.2.3 250mg
1.3 Crizotinib Capsules by Application
1.3.1 Global Crizotinib Capsules Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Crizotinib Capsules Market Size Estimates and Forecasts
1.4.1 Global Crizotinib Capsules Revenue 2021–2032
1.4.2 Global Crizotinib Capsules Sales 2021–2032
1.4.3 Global Crizotinib Capsules Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Crizotinib Capsules Market Competition by Manufacturers
2.1 Global Crizotinib Capsules Sales Market Share by Manufacturers (2021–2026)
2.2 Global Crizotinib Capsules Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Crizotinib Capsules Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Crizotinib Capsules, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Crizotinib Capsules, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Crizotinib Capsules, Product Types and Applications
2.7 Global Key Manufacturers of Crizotinib Capsules, Date of Entry into the Industry
2.8 Global Crizotinib Capsules Market Competitive Situation and Trends
2.8.1 Global Crizotinib Capsules Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Crizotinib Capsules Players Market Share by Revenue
2.8.3 Global Crizotinib Capsules Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Crizotinib Capsules Market Scenario by Region
3.1 Global Crizotinib Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Crizotinib Capsules Sales by Region: 2021–2032
3.2.1 Global Crizotinib Capsules Sales by Region: 2021–2026
3.2.2 Global Crizotinib Capsules Sales by Region: 2027–2032
3.3 Global Crizotinib Capsules Revenue by Region: 2021–2032
3.3.1 Global Crizotinib Capsules Revenue by Region: 2021–2026
3.3.2 Global Crizotinib Capsules Revenue by Region: 2027–2032
3.4 North America Crizotinib Capsules Market Facts & Figures by Country
3.4.1 North America Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Crizotinib Capsules Sales by Country (2021–2032)
3.4.3 North America Crizotinib Capsules Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Crizotinib Capsules Market Facts & Figures by Country
3.5.1 Europe Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Crizotinib Capsules Sales by Country (2021–2032)
3.5.3 Europe Crizotinib Capsules Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crizotinib Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Crizotinib Capsules Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Crizotinib Capsules Sales by Region (2021–2032)
3.6.3 Asia Pacific Crizotinib Capsules Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Crizotinib Capsules Market Facts & Figures by Country
3.7.1 Latin America Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Crizotinib Capsules Sales by Country (2021–2032)
3.7.3 Latin America Crizotinib Capsules Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Crizotinib Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Crizotinib Capsules Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Crizotinib Capsules Sales by Country (2021–2032)
3.8.3 Middle East and Africa Crizotinib Capsules Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crizotinib Capsules Sales by Type (2021–2032)
4.1.1 Global Crizotinib Capsules Sales by Type (2021–2026)
4.1.2 Global Crizotinib Capsules Sales by Type (2027–2032)
4.1.3 Global Crizotinib Capsules Sales Market Share by Type (2021–2032)
4.2 Global Crizotinib Capsules Revenue by Type (2021–2032)
4.2.1 Global Crizotinib Capsules Revenue by Type (2021–2026)
4.2.2 Global Crizotinib Capsules Revenue by Type (2027–2032)
4.2.3 Global Crizotinib Capsules Revenue Market Share by Type (2021–2032)
4.3 Global Crizotinib Capsules Price by Type (2021–2032)
5 Segment by Application
5.1 Global Crizotinib Capsules Sales by Application (2021–2032)
5.1.1 Global Crizotinib Capsules Sales by Application (2021–2026)
5.1.2 Global Crizotinib Capsules Sales by Application (2027–2032)
5.1.3 Global Crizotinib Capsules Sales Market Share by Application (2021–2032)
5.2 Global Crizotinib Capsules Revenue by Application (2021–2032)
5.2.1 Global Crizotinib Capsules Revenue by Application (2021–2026)
5.2.2 Global Crizotinib Capsules Revenue by Application (2027–2032)
5.2.3 Global Crizotinib Capsules Revenue Market Share by Application (2021–2032)
5.3 Global Crizotinib Capsules Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Crizotinib Capsules Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Qilu Pharmaceutical
6.2.1 Qilu Pharmaceutical Company Information
6.2.2 Qilu Pharmaceutical Description and Business Overview
6.2.3 Qilu Pharmaceutical Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Qilu Pharmaceutical Crizotinib Capsules Product Portfolio
6.2.5 Qilu Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Hengrui Medicine
6.3.1 Jiangsu Hengrui Medicine Company Information
6.3.2 Jiangsu Hengrui Medicine Description and Business Overview
6.3.3 Jiangsu Hengrui Medicine Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio
6.3.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.4 Chia Tai Tianqing Pharmaceutical Group
6.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information
6.4.2 Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
6.4.3 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio
6.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
6.5 Cipla Limited
6.5.1 Cipla Limited Company Information
6.5.2 Cipla Limited Description and Business Overview
6.5.3 Cipla Limited Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Limited Crizotinib Capsules Product Portfolio
6.5.5 Cipla Limited Recent Developments/Updates
6.6 Glenmark Pharmaceuticals
6.6.1 Glenmark Pharmaceuticals Company Information
6.6.2 Glenmark Pharmaceuticals Description and Business Overview
6.6.3 Glenmark Pharmaceuticals Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio
6.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.7 Natco Pharma
6.7.1 Natco Pharma Company Information
6.7.2 Natco Pharma Description and Business Overview
6.7.3 Natco Pharma Crizotinib Capsules Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Natco Pharma Crizotinib Capsules Product Portfolio
6.7.5 Natco Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crizotinib Capsules Industry Chain Analysis
7.2 Crizotinib Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crizotinib Capsules Production Mode & Process Analysis
7.4 Crizotinib Capsules Sales and Marketing
7.4.1 Crizotinib Capsules Sales Channels
7.4.2 Crizotinib Capsules Distributors
7.5 Crizotinib Capsules Customer Analysis
8 Crizotinib Capsules Market Dynamics
8.1 Crizotinib Capsules Industry Trends
8.2 Crizotinib Capsules Market Drivers
8.3 Crizotinib Capsules Market Challenges
8.4 Crizotinib Capsules Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Crizotinib Capsules Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Crizotinib Capsules Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Crizotinib Capsules Market Competitive Situation by Manufacturers in 2025
Table 4. Global Crizotinib Capsules Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Crizotinib Capsules Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Crizotinib Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Crizotinib Capsules Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Crizotinib Capsules Average Price (US$/Ton) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Crizotinib Capsules, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Crizotinib Capsules, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Crizotinib Capsules, Product Types and Applications
Table 12. Global Key Manufacturers of Crizotinib Capsules, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Crizotinib Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Crizotinib Capsules Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Crizotinib Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Crizotinib Capsules Sales by Region (Tons), 2021–2026
Table 18. Global Crizotinib Capsules Sales Market Share by Region (2021–2026)
Table 19. Global Crizotinib Capsules Sales by Region (Tons), 2027–2032
Table 20. Global Crizotinib Capsules Sales Market Share by Region (2027–2032)
Table 21. Global Crizotinib Capsules Revenue by Region (US$ Million), 2021–2026
Table 22. Global Crizotinib Capsules Revenue Market Share by Region (2021–2026)
Table 23. Global Crizotinib Capsules Revenue by Region (US$ Million), 2027–2032
Table 24. Global Crizotinib Capsules Revenue Market Share by Region (2027–2032)
Table 25. North America Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 27. North America Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 28. North America Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 29. North America Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 32. Europe Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 33. Europe Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Crizotinib Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Crizotinib Capsules Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Crizotinib Capsules Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Crizotinib Capsules Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Crizotinib Capsules Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 42. Latin America Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 43. Latin America Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 50. Global Crizotinib Capsules Sales (Tons) by Type (2021–2026)
Table 51. Global Crizotinib Capsules Sales (Tons) by Type (2027–2032)
Table 52. Global Crizotinib Capsules Sales Market Share by Type (2021–2026)
Table 53. Global Crizotinib Capsules Sales Market Share by Type (2027–2032)
Table 54. Global Crizotinib Capsules Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Crizotinib Capsules Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Crizotinib Capsules Revenue Market Share by Type (2021–2026)
Table 57. Global Crizotinib Capsules Revenue Market Share by Type (2027–2032)
Table 58. Global Crizotinib Capsules Price (US$/Ton) by Type (2021–2026)
Table 59. Global Crizotinib Capsules Price (US$/Ton) by Type (2027–2032)
Table 60. Global Crizotinib Capsules Sales (Tons) by Application (2021–2026)
Table 61. Global Crizotinib Capsules Sales (Tons) by Application (2027–2032)
Table 62. Global Crizotinib Capsules Sales Market Share by Application (2021–2026)
Table 63. Global Crizotinib Capsules Sales Market Share by Application (2027–2032)
Table 64. Global Crizotinib Capsules Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Crizotinib Capsules Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Crizotinib Capsules Revenue Market Share by Application (2021–2026)
Table 67. Global Crizotinib Capsules Revenue Market Share by Application (2027–2032)
Table 68. Global Crizotinib Capsules Price (US$/Ton) by Application (2021–2026)
Table 69. Global Crizotinib Capsules Price (US$/Ton) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 73. Pfizer Crizotinib Capsules Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Qilu Pharmaceutical Company Information
Table 76. Qilu Pharmaceutical Description and Business Overview
Table 77. Qilu Pharmaceutical Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 78. Qilu Pharmaceutical Crizotinib Capsules Product
Table 79. Qilu Pharmaceutical Recent Developments/Updates
Table 80. Jiangsu Hengrui Medicine Company Information
Table 81. Jiangsu Hengrui Medicine Description and Business Overview
Table 82. Jiangsu Hengrui Medicine Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 83. Jiangsu Hengrui Medicine Crizotinib Capsules Product
Table 84. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 85. Chia Tai Tianqing Pharmaceutical Group Company Information
Table 86. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
Table 87. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 88. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product
Table 89. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 90. Cipla Limited Company Information
Table 91. Cipla Limited Description and Business Overview
Table 92. Cipla Limited Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 93. Cipla Limited Crizotinib Capsules Product
Table 94. Cipla Limited Recent Developments/Updates
Table 95. Glenmark Pharmaceuticals Company Information
Table 96. Glenmark Pharmaceuticals Description and Business Overview
Table 97. Glenmark Pharmaceuticals Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 98. Glenmark Pharmaceuticals Crizotinib Capsules Product
Table 99. Glenmark Pharmaceuticals Recent Developments/Updates
Table 100. Natco Pharma Company Information
Table 101. Natco Pharma Description and Business Overview
Table 102. Natco Pharma Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 103. Natco Pharma Crizotinib Capsules Product
Table 104. Natco Pharma Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Crizotinib Capsules Distributors List
Table 108. Crizotinib Capsules Customers List
Table 109. Crizotinib Capsules Market Trends
Table 110. Crizotinib Capsules Market Drivers
Table 111. Crizotinib Capsules Market Challenges
Table 112. Crizotinib Capsules Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Crizotinib Capsules
Figure 2. Global Crizotinib Capsules Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Crizotinib Capsules Market Share by Type: 2025 & 2032
Figure 4. 200mg Product Picture
Figure 5. 250mg Product Picture
Figure 6. Global Crizotinib Capsules Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Crizotinib Capsules Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Crizotinib Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Crizotinib Capsules Market Size (US$ Million), 2021–2032
Figure 13. Global Crizotinib Capsules Sales (Tons), 2021–2032
Figure 14. Global Crizotinib Capsules Average Price (US$/Ton), 2021–2032
Figure 15. Crizotinib Capsules Report Years Considered
Figure 16. Crizotinib Capsules Sales Share by Manufacturers in 2025
Figure 17. Global Crizotinib Capsules Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Crizotinib Capsules Players: Market Share by Revenue in Crizotinib Capsules in 2025
Figure 19. Crizotinib Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Crizotinib Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 22. North America Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 23. United States Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 26. Europe Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 27. Germany Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Crizotinib Capsules Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Crizotinib Capsules Revenue Market Share by Region (2021–2032)
Figure 34. China Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 42. Latin America Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Crizotinib Capsules by Type (2021–2032)
Figure 53. Global Revenue Market Share of Crizotinib Capsules by Type (2021–2032)
Figure 54. Global Crizotinib Capsules Price (US$/Ton) by Type (2021–2032)
Figure 55. Global Sales Market Share of Crizotinib Capsules by Application (2021–2032)
Figure 56. Global Revenue Market Share of Crizotinib Capsules by Application (2021–2032)
Figure 57. Global Crizotinib Capsules Price (US$/Ton) by Application (2021–2032)
Figure 58. Crizotinib Capsules Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Crizotinib Capsules Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Crizotinib Capsules Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Crizotinib Capsules Market Competitive Situation by Manufacturers in 2025
Table 4. Global Crizotinib Capsules Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Crizotinib Capsules Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Crizotinib Capsules Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Crizotinib Capsules Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Crizotinib Capsules Average Price (US$/Ton) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Crizotinib Capsules, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Crizotinib Capsules, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Crizotinib Capsules, Product Types and Applications
Table 12. Global Key Manufacturers of Crizotinib Capsules, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Crizotinib Capsules Companies by Tier (Tier 1, Tier 2, Tier 3), based on Crizotinib Capsules Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Crizotinib Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Crizotinib Capsules Sales by Region (Tons), 2021–2026
Table 18. Global Crizotinib Capsules Sales Market Share by Region (2021–2026)
Table 19. Global Crizotinib Capsules Sales by Region (Tons), 2027–2032
Table 20. Global Crizotinib Capsules Sales Market Share by Region (2027–2032)
Table 21. Global Crizotinib Capsules Revenue by Region (US$ Million), 2021–2026
Table 22. Global Crizotinib Capsules Revenue Market Share by Region (2021–2026)
Table 23. Global Crizotinib Capsules Revenue by Region (US$ Million), 2027–2032
Table 24. Global Crizotinib Capsules Revenue Market Share by Region (2027–2032)
Table 25. North America Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 27. North America Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 28. North America Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 29. North America Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 32. Europe Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 33. Europe Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Crizotinib Capsules Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Crizotinib Capsules Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Crizotinib Capsules Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Crizotinib Capsules Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Crizotinib Capsules Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 42. Latin America Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 43. Latin America Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Crizotinib Capsules Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Crizotinib Capsules Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Crizotinib Capsules Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Crizotinib Capsules Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Crizotinib Capsules Revenue by Country (US$ Million), 2027–2032
Table 50. Global Crizotinib Capsules Sales (Tons) by Type (2021–2026)
Table 51. Global Crizotinib Capsules Sales (Tons) by Type (2027–2032)
Table 52. Global Crizotinib Capsules Sales Market Share by Type (2021–2026)
Table 53. Global Crizotinib Capsules Sales Market Share by Type (2027–2032)
Table 54. Global Crizotinib Capsules Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Crizotinib Capsules Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Crizotinib Capsules Revenue Market Share by Type (2021–2026)
Table 57. Global Crizotinib Capsules Revenue Market Share by Type (2027–2032)
Table 58. Global Crizotinib Capsules Price (US$/Ton) by Type (2021–2026)
Table 59. Global Crizotinib Capsules Price (US$/Ton) by Type (2027–2032)
Table 60. Global Crizotinib Capsules Sales (Tons) by Application (2021–2026)
Table 61. Global Crizotinib Capsules Sales (Tons) by Application (2027–2032)
Table 62. Global Crizotinib Capsules Sales Market Share by Application (2021–2026)
Table 63. Global Crizotinib Capsules Sales Market Share by Application (2027–2032)
Table 64. Global Crizotinib Capsules Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Crizotinib Capsules Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Crizotinib Capsules Revenue Market Share by Application (2021–2026)
Table 67. Global Crizotinib Capsules Revenue Market Share by Application (2027–2032)
Table 68. Global Crizotinib Capsules Price (US$/Ton) by Application (2021–2026)
Table 69. Global Crizotinib Capsules Price (US$/Ton) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 73. Pfizer Crizotinib Capsules Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Qilu Pharmaceutical Company Information
Table 76. Qilu Pharmaceutical Description and Business Overview
Table 77. Qilu Pharmaceutical Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 78. Qilu Pharmaceutical Crizotinib Capsules Product
Table 79. Qilu Pharmaceutical Recent Developments/Updates
Table 80. Jiangsu Hengrui Medicine Company Information
Table 81. Jiangsu Hengrui Medicine Description and Business Overview
Table 82. Jiangsu Hengrui Medicine Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 83. Jiangsu Hengrui Medicine Crizotinib Capsules Product
Table 84. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 85. Chia Tai Tianqing Pharmaceutical Group Company Information
Table 86. Chia Tai Tianqing Pharmaceutical Group Description and Business Overview
Table 87. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 88. Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product
Table 89. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
Table 90. Cipla Limited Company Information
Table 91. Cipla Limited Description and Business Overview
Table 92. Cipla Limited Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 93. Cipla Limited Crizotinib Capsules Product
Table 94. Cipla Limited Recent Developments/Updates
Table 95. Glenmark Pharmaceuticals Company Information
Table 96. Glenmark Pharmaceuticals Description and Business Overview
Table 97. Glenmark Pharmaceuticals Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 98. Glenmark Pharmaceuticals Crizotinib Capsules Product
Table 99. Glenmark Pharmaceuticals Recent Developments/Updates
Table 100. Natco Pharma Company Information
Table 101. Natco Pharma Description and Business Overview
Table 102. Natco Pharma Crizotinib Capsules Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
Table 103. Natco Pharma Crizotinib Capsules Product
Table 104. Natco Pharma Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Crizotinib Capsules Distributors List
Table 108. Crizotinib Capsules Customers List
Table 109. Crizotinib Capsules Market Trends
Table 110. Crizotinib Capsules Market Drivers
Table 111. Crizotinib Capsules Market Challenges
Table 112. Crizotinib Capsules Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Crizotinib Capsules
Figure 2. Global Crizotinib Capsules Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Crizotinib Capsules Market Share by Type: 2025 & 2032
Figure 4. 200mg Product Picture
Figure 5. 250mg Product Picture
Figure 6. Global Crizotinib Capsules Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Crizotinib Capsules Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Crizotinib Capsules Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Crizotinib Capsules Market Size (US$ Million), 2021–2032
Figure 13. Global Crizotinib Capsules Sales (Tons), 2021–2032
Figure 14. Global Crizotinib Capsules Average Price (US$/Ton), 2021–2032
Figure 15. Crizotinib Capsules Report Years Considered
Figure 16. Crizotinib Capsules Sales Share by Manufacturers in 2025
Figure 17. Global Crizotinib Capsules Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Crizotinib Capsules Players: Market Share by Revenue in Crizotinib Capsules in 2025
Figure 19. Crizotinib Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Crizotinib Capsules Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 22. North America Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 23. United States Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 26. Europe Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 27. Germany Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Crizotinib Capsules Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Crizotinib Capsules Revenue Market Share by Region (2021–2032)
Figure 34. China Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 42. Latin America Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Crizotinib Capsules Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Crizotinib Capsules Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Crizotinib Capsules Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Crizotinib Capsules by Type (2021–2032)
Figure 53. Global Revenue Market Share of Crizotinib Capsules by Type (2021–2032)
Figure 54. Global Crizotinib Capsules Price (US$/Ton) by Type (2021–2032)
Figure 55. Global Sales Market Share of Crizotinib Capsules by Application (2021–2032)
Figure 56. Global Revenue Market Share of Crizotinib Capsules by Application (2021–2032)
Figure 57. Global Crizotinib Capsules Price (US$/Ton) by Application (2021–2032)
Figure 58. Crizotinib Capsules Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232